GEMIN3 Gene

GEMIN3 Gene

Introduction

Gemin3 Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

<div class="infobox infobox-gene"> [@supsup2002]
<div class="infobox-header">GEMIN3</div> [@supsup2002a]
<div class="infobox-row"><strong>Full Name:</strong> Gem Nuclear Organelle Associated Protein 3 (also known as DDX20)</div> [@supsup2013]
<div class="infobox-row"><strong>Symbol:</strong> GEMIN3</div>
<div class="infobox-row"><strong>Chromosomal Location:</strong> 1p36.22</div>
<div class="infobox-row"><strong>NCBI Gene ID:</strong> 50814</div>
<div class="infobox-row"><strong>UniProt ID:</strong> O75940</div>
<div class="infobox-row"><strong>Ensembl ID:</strong> ENSG00000089356</div>
<div class="infobox-row"><strong>Associated Diseases:</strong> Amyotrophic Lateral Sclerosis (ALS), Spinal Muscular Atrophy (SMA)</div>
</div>

Overview

This section provides a summary of the gene/protein's function, expression, and relevance to neurodegenerative diseases.

Function

GEMIN3 (Gem Nuclear Organelle Associated Protein 3), also known as DDX20 (DEAD-Box Helicase 20), is a member of the DEAD-box RNA helicase family and a core component of the SMN complex. It plays essential roles in RNA metabolism through its helicase activity and as a scaffold protein.

Biochemical Properties

GEMIN3 Gene

Introduction

Gemin3 Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

<div class="infobox infobox-gene"> [@supsup2002]
<div class="infobox-header">GEMIN3</div> [@supsup2002a]
<div class="infobox-row"><strong>Full Name:</strong> Gem Nuclear Organelle Associated Protein 3 (also known as DDX20)</div> [@supsup2013]
<div class="infobox-row"><strong>Symbol:</strong> GEMIN3</div>
<div class="infobox-row"><strong>Chromosomal Location:</strong> 1p36.22</div>
<div class="infobox-row"><strong>NCBI Gene ID:</strong> 50814</div>
<div class="infobox-row"><strong>UniProt ID:</strong> O75940</div>
<div class="infobox-row"><strong>Ensembl ID:</strong> ENSG00000089356</div>
<div class="infobox-row"><strong>Associated Diseases:</strong> Amyotrophic Lateral Sclerosis (ALS), Spinal Muscular Atrophy (SMA)</div>
</div>

Overview

This section provides a summary of the gene/protein's function, expression, and relevance to neurodegenerative diseases.

Function

GEMIN3 (Gem Nuclear Organelle Associated Protein 3), also known as DDX20 (DEAD-Box Helicase 20), is a member of the DEAD-box RNA helicase family and a core component of the SMN complex. It plays essential roles in RNA metabolism through its helicase activity and as a scaffold protein.

Biochemical Properties

• RNA Helicase Activity: Unwinds RNA duplexes in an ATP-dependent manner
• ATPase Activity: Uses ATP hydrolysis to power conformational changes
• RNA Binding: Binds various RNA species including snRNA, miRNA, and mRNA

Functions in RNA Processing

• Spliceosomal snRNP Assembly: Facilitates proper assembly of the SMN complex with snRNA
• miRNA Biogenesis: Involved in microRNA processing through interaction with the microprocessor complex
• Transcriptional Regulation: Modulates gene expression through interactions with transcription factors

Disease Associations

Amyotrophic Lateral Sclerosis (ALS)

GEMIN3 is implicated in ALS pathogenesis through multiple mechanisms:

Spinal Muscular Atrophy (SMA)

GEMIN3 polymorphisms can modify SMA severity by affecting SMN complex function.

Expression

GEMIN3 is widely expressed with high levels in:

• Motor [neurons](/entities/neurons) of the spinal cord
• Brain ([hippocampus](/brain-regions/hippocampus), cortex)
• Testis and thymus
• Cardiac muscle

Biochemical Properties

Enzyme Activity

GEMIN3 is a ATP-dependent RNA helicase:

• DEAD box motif: Characteristic sequence of DEAD-box helicases
• RNA binding: Binds single-stranded RNA
• Unwinding activity: Separates RNA duplexes
• ATP hydrolysis: Powers conformational changes

SMN Complex

GEMIN3 is a core component of the SMN complex:

• SMN (SMN1/SMN2): Central hub protein
• Gemins (2-7): Accessory proteins
• snRNA binding: Associates with spliceosomal snRNAs
• snoRNA binding: Associates with small nucleolar RNAs

Molecular Mechanisms

Spliceosome Assembly

GEMIN3 functions in snRNP biogenesis:

miRNA Processing

GEMIN3 participates in microRNA biogenesis:

• Microprocessor interaction: Associates with DROSHA
• Pri-miRNA processing: Cleaves primary miRNA transcripts
• Alternative processing: May process specific subsets

Stress Granules

GEMIN3 localizes to stress granules:

• mRNA sequestration: Stores translationally arrested mRNAs
• Stress response: Protects mRNAs during stress
• TDP-43 colocalization: In ALS pathology
• Dynamic cycling: Enters and exits granules

Disease Mechanisms

RNA Metabolism Defects

In ALS, GEMIN3 dysfunction causes:

• Splicing defects: Aberrant mRNA splicing
• RNA granules: Abnormal stress granule formation
• Transport defects: Impaired RNA trafficking
• Translation dysregulation: Altered protein synthesis

TDP-43 Pathology

GEMIN3 interacts with TDP-43:

• Co-aggregation: Found in ALS inclusions
• RNA binding competition: Compete for target RNAs
• Sequestration: Loss of function in granules
• Toxicity amplification: Synergistic pathogenic effects

SMA Modification

GEMIN3 variants modify SMA:

• Severity modifiers: Genetic modifiers of severity
• SMN complex function: Altered complex assembly
• Residual function: Determines disease course
• Therapeutic response: May affect treatment response

Therapeutic Approaches

Small Molecule Strategies

Gene Therapy

• GEMIN3 expression: Restore normal levels
• Allele-specific: Target specific variants
• Combination therapy: With SMN-enhancing approaches

RNA-Based Therapies

• ASOs: Antisense oligonucleotides
• siRNA: Knockdown of toxic variants
• miRNA modulators: Affect miRNA processing

Animal Models

Knockout Studies

• Embryonic lethal: Complete knockout is lethal
• Conditional knockout: Tissue-specific studies
• Phenotypes: Motor neuron deficits

Transgenic Models

• Overexpression: Human GEMIN3 expression
• Mutant variants: Disease-associated mutations
• Rescue studies: Therapeutic testing

Key Publications

Therapeutic Targeting

Potential therapeutic approaches include:

• RNA-based therapies targeting GEMIN3 expression
• Small molecule helicase modulators
• Gene therapy to correct pathogenic mutations

See Also

• [SMN1 Gene](/genes/smn1)
• [SMN2 Gene](/genes/smn2)
• [GEMIN1 Gene](/genes/gemin1)
• [GEMIN2 Gene](/genes/gemin2)
• [GEMIN4 Gene](/genes/gemin4)
• [DDX1 Gene](/genes/ddx1)
• [DDX5 Gene](/genes/ddx5)
• [Amyotrophic Lateral Sclerosis](/diseases/amyotrophic-lateral-sclerosis)
• [TDP-43 Proteinopathy](/mechanisms/tdp-43-proteinopathy)
• [Stress Granules in Neurodegeneration](/mechanisms/stress-granules-neurodegeneration)
• [Spinal Muscular Atrophy](/diseases/spinal-muscular-atrophy)

External Links

• [NCBI Gene: GEMIN3](https://www.ncbi.nlm.nih.gov/gene/50814)
• [UniProt: O75940](https://www.uniprot.org/uniprot/O75940)
• [OMIM: GEMIN3](https://www.omim.org/entry/608592)

References